SKU:
Description
Our Sales Team
Request a Quote-
Stephanie McCullough
Sales Executive, Primary and Acute Care
-
Alyson Kamlani
Strategic Account Manager, Primary and Acute Care
-
Laura Senel
National Account Manager, Government
-
Tim Hash, BSRT(T)
Sales Manager, Radiation Therapy
-
April Mattingly, RT(T)
Midwest | Southeast Account Manager, Radiation Therapy
-
Jennifer Pearcy
Northeast Account Manager, Radiation Therapy
-
Tom Craig
Account Manager, International
-
Shaun Gensler
Account Manager, International
-
Zak Huttner
National Account Manager, Distribution
-
Josephine Murphy
Program Manager, Safety & Compliance
-
Chris Becker
President and Chief Executive Officer
-
Jason Zilles
Chief Financial Officer
-
James Schmalz
Vice President of Operations
-
Thomas Thunder, AuD, INCE(Emeritus) - Audiologist and Noise Engineer
Bionix Primary Care Clinical Advisory Board Member
-
Alison Krieger
Customer Service Manager
-
Katie Hornstein
Data Exchange Specialist
-
Theresa Erdmann
Customer Service Representative
-
Nikita Powell
Customer Service Representative
-
Johnny Powers
Customer Service Representative
-
Renee Reikowski
Customer Service Representative
-
Lauren Walczak
Customer Service Representative
-
Jeffery Bender, MD
Bionix Primary Care Clinical Advisory Board Member
-
Valerie Pauli EdD, MSN, RN, ACNS-BC, CNE
Bionix Primary Care Clinical Advisory Board Member
-
Kathryn Davis, MD, FAAP
Bionix Primary Care Clinical Advisory Board Member
-
James Huttner, MD, PhD
Co-Founder, Director of Medical Innovations, Primary Care Clinical Advisory Board Member
-
Jim Chandler
Customer Relations Specialist, Primary and Acute Care
Related Products
Related News
Bionix Announces Renewed Focus on Ear, Nose and Thoat Care
Bionix® divests its Radiation Therapy unit to CQ Medical to accelerate growth in Ear, Nose and Throat Care.
Read More
December 1, 2025
Why Manufacturing Location Matters More Than Ever
Most Bionix products are made in the U.S.A., helping us deliver consistent quality and avoid tariff-related price increases.
Read More
May 1, 2025
